共 50 条
- [22] Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer Advances in Therapy, 2023, 40 : 4919 - 4927
- [23] Androgen deprivation therapy in advanced prostate cancer. Multicenter study ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (06): : 499 - 508
- [25] Androgen deprivation therapy in locally advanced prostate cancer PROGRES EN UROLOGIE, 2010, 20 : S68 - S71
- [26] Intermittent Androgen Deprivation Therapy in Advanced Prostate Cancer Current Treatment Options in Oncology, 2014, 15 : 127 - 136
- [29] HERO PHASE 3 TRIAL: RESULTS COMPARING RELUGOLIX, AN ORAL GNRH RECEPTOR ANTAGONIST, VS LEUPROLIDE ACETATE FOR ADVANCED PROSTATE CANCER JOURNAL OF UROLOGY, 2020, 203 : E1117 - E1117
- [30] Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial LANCET, 2011, 378 (9809): : 2104 - 2111